Assignee
FIVE ELEVEN PHARMA INC
US·5 granted patents·3 pending applications·17 citations·filing 2016–2021
Top patents by PatentIndex Score
8 records- 0188US10912849B2Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological applicationFIVE ELEVEN PHARMA INC·Filed 2018·Granted Feb 9, 2021·6 cites·16 claims
- 0288US10688200B2Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapyFIVE ELEVEN PHARMA INC·Filed 2016·Granted Jun 23, 2020·8 cites·22 claims
- 0381US11071794B2Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological applicationFIVE ELEVEN PHARMA INC·Filed 2020·Granted Jul 27, 2021·2 cites·13 claims
- 0472US12544463B2Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological applicationFIVE ELEVEN PHARMA INC·Filed 2021·Granted Feb 10, 2026·0 cites·11 claims
- 0564US10253052B2HBED-bisphosphonates, radiometal conjugates and their use as theranostic agentsFIVE ELEVEN PHARMA INC·Filed 2016·Granted Apr 9, 2019·1 cites·28 claims
- 0649US2024158420A1[18f]a1f labeled psma targeting molecular probe and preparation method thereforFIVE ELEVEN PHARMA INC·Filed 2021·Application pending·0 cites
- 0749US2024139350A1Radioactively labeled ligand for fibroblast activation protein-alpha imaging agent and preparation method thereforFIVE ELEVEN PHARMA INC·Filed 2021·Application pending·0 cites
- 0846US2022125959A1Prostate-specific membrane antigen (psma) inhibitors as diagnostic and radionuclide therapeutic agentsFIVE ELEVEN PHARMA INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →